Phathom Pharmaceuticals's total assets for Q1 2026 were $305.12M, an increase of 17.74% from the previous quarter. PHAT total liabilities were $642.08M for the fiscal quarter, a -7.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.